Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. 1980

K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito

Studies were made on the dose response of saccharin in the induction of bladder lesions. Inbred F344 rats of both sexes were pretreated with 100 ppm N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in the drinking water for 4 weeks. Sodium saccharin was given at 50,000, 10,000, 2,000, and 400 ppm in the diet for 32 weeks after BBN administration, and surviving rats were killed at the end of week 36 of the experiment. No increase in incidence of papilloma or cancer was noted in either sex at any dose of saccharin after BBN as compared to levels induced by BBN alone. The incidences of two types of hyperplasia and average number of papillary or nodular hyperplasias per 10 cm of basement membrane were significantly increased in the group receiving 50,000 ppm saccharin as compared to the group given BBN only. None of the incidences or numbers of these lesions were significantly different in any of the other saccharin-treated groups when compared to the group treated with BBN alone except for the incidences of two types of hyperplasias in the female rats dosed with 10,000 ppm saccharin. Dose-response curves showed enhanced hyperplastic responses in both sexes given 2,000--50,000 ppm saccharin. Administration of various doses of saccharin without BBN did not cause any changes in the urinary bladders of rats of either sex. These results show that saccharin enhances the induction of early-stage bladder lesions and that the biologic response demonstrates a dose-response effect.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002085 Butylhydroxybutylnitrosamine A substituted carcinogenic nitrosamine. Butylbutanolnitrosamine,N-Butyl-N-(4-hydroxybutyl)nitrosamine,N-Nitroso-N-butyl-(4-hydroxybutyl)amine,N-Nitrosobutyl-4-hydroxybutylamine,N Nitrosobutyl 4 hydroxybutylamine
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
January 1984, Journal of cancer research and clinical oncology,
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
October 2000, Cancer research,
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
January 1983, Carcinogenesis,
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
August 1980, Gan,
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
September 1985, Japanese journal of cancer research : Gann,
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
January 2024, Methods in molecular biology (Clifton, N.J.),
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
August 1969, Gan,
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
August 1987, Journal of the National Cancer Institute,
K Nakanishi, and A Hagiwara, and M Shibata, and K Imaida, and M Tatematsu, and N Ito
January 2018, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!